Proinflammatory cytokines, hepatocyte growth factor and adipokines in peritoneal dialysis patients

Artificial Organs

Volumn 34, Issue 7, 2010, Pages

  Lee, Chien Te ^a   Ng, Hwee Yeong ^a   Hsu, Chung Yao ^b   Tsai, Yu Che ^a   Yang, Yu Kun ^a   Chen, Te Chuan ^a   Chiou, Terry Ting Yu ^a   Kuo, Chien Chun ^a   Lee, Wen Chin ^a   Hsu, Kao Tai ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adipokine; Hepatocyte growth factor; Inflammation; Inflammatory cytokine; Peritoneal dialysis

Indexed keywords

DIALYSIS; TISSUE;

ADIPOKINE; ADIPOKINES; HEPATOCYTE GROWTH FACTOR; INFLAMMATORY CYTOKINES; INTERLEUKIN-10; INTERLEUKIN-18; INTERLEUKIN6 (IL6); PERITONEAL DIALYSIS; PROINFLAMMATORY CYTOKINES; TNF Α;

PATHOLOGY;

ADIPOCYTOKINE; ADIPONECTIN; ALBUMIN; C REACTIVE PROTEIN; CYTOKINE; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; LEPTIN; RESISTIN; SCATTER FACTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; CORRELATION ANALYSIS; DIALYSATE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERITONEAL DIALYSIS; PERITONEAL TRANSPORT RATE; PERITONEUM; PRIORITY JOURNAL; RESIDUAL KIDNEY FUNCTION; TRANSPORT KINETICS; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; INFLAMMATION; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; TRANSPORT AT THE CELLULAR LEVEL;

ADIPOKINES; ADULT; BIOLOGICAL TRANSPORT; BODY MASS INDEX; CYTOKINES; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATION; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM;

EID: 77954381132     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01000.x     Document Type: Article

References (31)

1. Stenvinkel P, Chung SH, Heimbürger O, Lindholm B. Malnutrition, inflammation and atherosclerosis in peritoneal dialysis patients. Perit Dial Int 2001 21 (Suppl 3 157 162.
2. Jofré R, Rodriguez-Benitez P, López-Gómez JM, Pérez-Garcia R. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol 2006 17 : S274 80.
3. Chung SH, Heimbürger O, Bengt L, Stenvinkel P. Chronic inflammation in PD patients. Contrib Nephrol 2003 140 : 104 111.
4. Ross R. Atherosclerosis - an inflammatory disease. N Eng J Med 1999 340 : 115 126.
5. Noh H, Lee SW, Kang SW, et al. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1998 18 : 387 394.
6. Pecoits-Filho R, Bárány P, Lindholm B, Heimbürger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002 17 : 1684 1688.
7. Chiang CK, Hsu SP, Pai MF, et al. Interleukin-18 is a strong predictor of hospitalization in haemodialysis patients. Nephrol Dial Transplant 2004 19 : 2810 2815.
8. Zoccali C, Mallamaci F, Tripepi G. Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. Kidney Int 2003 Suppl 84 65 8.
9. Guzik TJ, Mangalat D, Korbut R. Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol 2006 57 : 505 528.
10. Twardowski ZJ. PET - a simpler approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial 1990 6 : 186 191.
11. Panichi V, Maggiore U, Taccola D, et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrol Dial Transplant 2004 19 : 1154 1160.
12. Pecoits-Filho R, Lindholm B, Axelsson J, Stenvinkel P. Update on interleukin-6 and its role in chronic renal failure. Nephrol Dial Transplant 2003 18 : 1042 1045.
13. Girndt M, Ulrich C, Kaul H, Sester U, Sester M, Köhler H. Uremia-associated immune defect: the IL-10-CRP axis. Kidney Int 2003 Suppl 84 S76 9.
14. Stenvinkel P, Pecoits-Filho R, Lindholm B. Gene polymorphism association studies in dialysis: the nutrition-inflammation axis. Semin Dial 2005 18 : 322 330.
15. Yang JY, Huang JW, Chiang CK, et al. Higher plasma interleukin-18 levels associated with poor quality of sleep in peritoneal dialysis patients. Nephrol Dial Transplant 2007 22 : 3606 3609.
16. Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007 27 : 98 114.
17. Díez JJ, Iglesias P, Fernández-Reyes MJ, et al. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf) 2005 62 : 242 249.
18. Lee CT, Lee CH, Su Y, Chuang YC, Tsai TL, Chen JB. The relationship between inflammatory markers, leptin and adiponectin in chronic hemodialysis patients. Int J Artif Organs 2004 27 : 835 841.
19. Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Ren Fail 2007 29 : 147 154.
20. Norata GD, Raselli S, Grigore L, et al. Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 2007 38 : 2844 2846.
21. Teta D, Maillard M, Halabi G, Burnier M. The leptin/adiponectin ratio: potential implications for peritoneal dialysis. Kidney Int 2008 73 : S112 8.
22. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995 345 : 293 295.
23. Lee CT, Hsu CY, Lam KK, Lin CR, Chen JB. Inflammatory markers and hepatocyte growth factor in sustained hemodialysis hypotension. Artif Organs 2005 29 : 980 983.
24. Malatino LS, Mallamaci F, Benedetto FA, et al. Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis 2000 36 : 945 952.
25. Anan F, Shimomura T, Imagawa M, et al. H. Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis. Metabolism 2007 56 : 593 598.
26. Matsuo K, Maeda Y, Naiki Y, et al. Possible effects of hepatocyte growth factor for the prevention of peritoneal fibrosis. Nephron Exp Nephrol 2005 99 : e87 94.
27. Nakamura S, Niwa T. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage. J Am Soc Nephrol 2005 16 : 144 150.
28. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001 12 : 2158 2162.
29. Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int 2006 69 : 1726 1732.
30. Heaf JG, Sarac S, Afzal S. A high peritoneal fluid flux causes hypoalbuminemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant 2005 20 : 2194 2201.
31. Oh KH, Moon JY, Oh J, et al. Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients. Nephrol Dial Transplant 2008 23 : 2356 2364.